🇺🇸 FDA
Patent

US 9173882

Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

granted A61KA61K31/502A61P

Quick answer

US patent 9173882 (Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/502, A61P, A61P13/12, A61P15/00